Curanex Pharmaceuticals, Inc. (CURX)
4.410
-0.03
(-0.67%)
USD |
NASDAQ |
Nov 20, 16:00
4.44
+0.03
(+0.67%)
After-Hours: 20:00
Curanex Pharmaceuticals Total Assets (Quarterly) : 3.097M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 3.097M |
| June 30, 2026 | 5.074M |
| March 31, 2026 | 8.411M |
| December 31, 2025 | 11.58M |
| September 30, 2025 | 14.48M |
| June 30, 2025 | 0.7872M |
| Date | Value |
|---|---|
| March 31, 2025 | 0.7869M |
| December 31, 2024 | 0.5179M |
| September 30, 2024 | 0.6461M |
| June 30, 2024 | 0.7158M |
| March 31, 2024 | |
| December 31, 2023 | 0.0744M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Breakthrough Chemistry, Inc. | 0.6168M |
| Kaya Holdings, Inc. | 0.1994M |
| Cardiac Biotech Solutions, Inc. | 0.4511M |
| Endexx Corp. | -- |
| Earth Science Tech, Inc. | 10.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.5518M |
| Shareholders Equity (Quarterly) | 2.545M |
| Debt to Equity Ratio | 0.213 |
| Current Ratio | 17.84 |
| Net Debt Paydown Yield | -0.17% |